Immunotherapeutic strategies for hepatocellular carcinoma

This publication has 32 references indexed in Scilit:

• Prospective Pilot Study of Recombinant Granulocyte-Macrophage Colony-Stimulating Factor and Interferon-γ in Patients With Inoperable Hepatocellular Carcinoma
  Journal of Immunotherapy, 2002
• Cirrhotic Patients With or Without Hepatocellular Carcinoma Harbour AFP-Specific T-Lymphocytes That Can Be Activated in vitro by Human Alpha-Fetoprotein
  Scandinavian Journal of Gastroenterology, 2002
• Effective treatment of small murine hepatocellular carcinoma by dendritic cells
  Hepatology, 2001
• Mouse α-fetoprotein–specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice
  Gastroenterology, 2000
• High Frequency of The Mage–1 Gene Expression in Hepatocellular Carcinoma
  Hepatology, 1996
• Adjuvant Chemoimmunotherapy for Hepatocellular Carcinoma Patients
  American Journal of Clinical Oncology, 1995
• Combined Transarterial Targeting Locoregional Immunotherapy-Chemotherapy for Patients with Unresectable Hepatocellular Carcinoma: A New Alternative for an Old Problem
  Journal of Interferon & Cytokine Research, 1995
• Effective Tumor Vaccine Generated by Fusion of Hepatoma Cells with Activated B Cells
  Science, 1994
• MHC molecules as peptide receptors
  Current Opinion in Immunology, 1993
• Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies. A preliminary report
  Cancer, 1991